← Research library

Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.

Controlled study in people · 1987

What was studied
14 middle-aged patients with chronic insomnia
Main finding
A 14-person placebo-controlled insomnia report described improved sleep and daytime performance over seven nights of DSIP, without giving numerical sleep or performance effect sizes in its abstract.

Reported findings and study design

A 14-person placebo-controlled insomnia report described improved sleep and daytime performance over seven nights of DSIP, without giving numerical sleep or performance effect sizes in its abstract.

14 middle-aged chronic insomniacs; double-blind placebo-controlled administration and polysomnography.

Results · Primary-publication indexed abstract; no full-text table appraisal
MeasureResultComparison, timing and statistics
Sleep and daytime performanceReported improvements; numerical changes not suppliedSleep effects reportedly persisted on the first placebo post-treatment night
Participants14 chronic-insomnia patients
Observation schedule7 successive treatment nights; daytime testing before and after 6 injections

This positive report is shown alongside the separate weak/neutral DSIP comparisons; their findings should not be pooled without full methods.

Source for these results ↗ · Reviewed 2026-11-01

Study limitations and source details

Study limitations

  • Small sample and short follow-up; allocation and complete methods require appraisal.

Source details

Indexed metadata and abstract checked via PubMed / Europe PMC; full methods and risk-of-bias assessment pending.

Sources checked

Citation

Clinical trial / comparisonEnglish abstract

Schneider-Helmert D. Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia. European neurology 27(2):120-129

Study source ↗ · DOI 10.1159/000116143 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards